Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases.

Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases.
Turk Kardiyol Dern Ars. 2019 Jan;47(1):63-68
Authors: Güner A, Bayam E, Kalkan S, Gündüz S, Özkan M
Abstract
Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.
PMID: 30628904 [PubMed - in process]

Source: Turk Kardiyoloji Dernegi arsivi - January 1, 2019 Category: Cardiology Authors: Güner A, Bayam E, Kalkan S, Gündüz S, Özkan M Tags: Turk Kardiyol Dern Ars Source Type: research